International cooperation


Amgros has a vision to be internationally recognised as a role model in translating healthcare needs into action. We work with other countries to share knowledge and achieve a broader perspective. Amgros has relationships with a large number of European countries, individually and under the auspices of the EU and the WHO. The most developed are our relationships with the other Nordic countries as well as the Beneluxa-Ireland initiative

Together we are larger and stronger. This is the fundamental philosophy behind our work with players in other countries. Denmark is a small country with a small market, but with other countries, we can enhance our position and become a stronger cooperation partner for suppliers. At the same time, suppliers can be part of a bigger market. This should benefit all parties.

Our international cooperation also gives us insight and overview that we use when we advise and discuss matters concerning developments in the Danish Health service with our national cooperation partners.

Amgros has relationships with a large number of countries individually, in networks, in alliances across national borders, and under the auspices of the EU and the WHO. The most developed of these are our relationships with the other Nordic countries and the Beneluxa-Ireland initiative.

INCREASING PRICES AND SECURITY OF SUPPLY

Denmark faces the same challenges as many other countries. In particular, the prices of new drugs and the increasing number of long-term supply disruptions for older drugs.
The pharmaceuticals market is international, and decisions in other countries can influence the Danish market. Therefore, Amgros has focus on developing our international relationships and being aware of where we can buy products or have alternative drugs manufactured.

All countries have the same problems with increasing pharmaceuticals prices and growing challenges with regard to security of supply. Therefore, it’s obvious to seek inspiration from our colleagues in other countries. We use resources to strengthen our international cooperation, because we believe that in the longer term this will be in the interests of Danish patients.
Flemming Sonne,
CEO

NORDIC PHARMACEUTICALS FORUM

In 2015, Amgros took initiative to establish the Nordic Pharmaceuticals Forum (Nordisk Lægemiddelforum). The collaboration focusses on sharing knowledge and working towards common Nordic solutions. An important challenge is to make it attractive to supply pharmaceuticals to the Nordic countries, as in a global context they are only very small markets.

SIX AREAS FOR COOPERATION

Cooperation in the Nordic Pharmaceuticals Forum is based on the principles of voluntariness, consensus, joint responsibility and joint financing.

So far, cooperation is in five areas, with focus on knowledge-sharing and mutual inspiration: Horizon Scanning, Security of supply, New, expensive pharmaceuticals, Manufacture, the Environment and Joint Nordic tendering procedures.

Cooperation in some areas is under development, while in others it is more specific and proactive. For example, Denmark, Norway and Iceland have now completed two joint Nordic tendering procedure for medicines. The individual countries are only involved in projects that are relevant for them.

ORGANISATION

The Nordic Pharmaceuticals Forum is organised with a steering group comprising representatives from the individual countries as well as working groups for prioritised areas.

The steering group includes representatives from each country and a coordinator. Denmark holds the chairmanship.

AGREEMENT OF INTENT WITH NORWAY

As a natural continuation of cooperation within the Nordic Pharmaceuticals Forum, in September 2018 Norway and Denmark entered into a political agreement on increased cooperation, including joint tendering procedures and price negotiations.

Read more about the agreement of intent. (Only available in Danish).


Second joint Nordic tendering procedure for medicines completed

Together with Norway and Iceland, we have now completed our second joint Nordic tendering procedure for medicines. This is the first time that Iceland joined in the agreements, and environmental requirements were part of the criteria.

YES - I WANT TO READ THE ARTICLE
INTERNATIONAL NETWORKS AND ALLIANCES PROVIDE GLOBAL PERSPECTIVES

An important part of our international work is to find inspiration from how our colleagues in other countries manage challenges. We are also proactive and we bring our own knowledge into play so that others can learn from our experience. We are all facing many of the same challenges, such as increasing expenditure on medicines and growing problems in securing supplies of medicines for hospitals and patients.

Amgros takes part in a number of European networks on medicines pricing, tendering procedures, procurement, Horizon Scanning and more.

We are also part of a number of best practice alliances, such as the Beneluxa-Ireland initiative, the pan-Canadian Pharmaceutical Alliance (pCPA) and, as already mentioned, the Nordisk Lægemiddelforum (Nordic Pharmaceuticals Forum), in which we work together to find procedures to help improve patients’ access to the right medicines.


European collaboration to bolster access to medicines

Denmark and the other countries in the Nordisk Lægemiddelforum (Nordic Pharmaceuticals Forum) are working with Beneluxa to find procedures to help patients to access new, expensive pharmaceuticals. The countries have published a joint statement.

YES - I want to read the full article

Read more

International cooperation

National cooperation

Amgros plays an active role in developing the healthcare system. We forge cooperation with and between all parties who help ensure that hospitals have the right pharmaceuticals, hearing aids and medical devices available to treat patients at public hospitals.

READ MORE
International cooperation

Cooperation partners

In a complex landscape with many players, our focus is on securing solid operations, while at the same time thinking innovatively and being flexible and agile.

READ MORE